Vistagen: Pherine Candidate Proof Of Concept Continues With Fifth Indication
Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...
Dance of magnetism and light: Study finds nonreciprocal second harmonic generation disappears in 2D material
A research group recently discovered the disappearance of nonreciprocal second harmonic generation (SHG) in MnPSe₃ when ...
Scientists propose CDK2 enzyme as new target for cancer therapy
An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...
Science Friday5h
The FDA Approves A New, Non-Opioid Painkiller
It’s the first FDA approval for a pain medication in 25 years. How does the drug work, and who is it for?
Business Wire3h
U.S. FDA Grants Full Approval of Deciphera’s ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) ...
Coastal Review Online8h
Upriver Cape Fear plant releases high levels of 1,4-dioxane
Levels of the compound believed to be a human carcinogen at the Asheboro wastewater treatment plant far exceeded national ...